SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.3% of their position (7.50K shares) of IRADIMED CORP on the open market
Open‑market sale worth $763.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/18/2026ACC: 0001613801-26-000016
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-7.50K
Net shares
Net seller
$763.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.50K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−3.01K
Price / share
$101.18
Trade value
$304.45K
% of position
0.1%
3/16/2026
2.25M→2.24M
Common Stock
Indirect
Shares
−1.99K
Price / share
$101.68
Trade value
$202.44K
% of position
0.1%
3/16/2026
2.24M→2.24M
Common Stock
Indirect
Shares
−2.50K
Price / share
$102.43
Trade value
$256.08K
% of position
0.1%
3/17/2026
2.24M→2.24M
Total
Net shares
−7.50K
Net value
-$762.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/16/2026 | S · Sale | −3.01K | $101.18 | $304.45K | 0.1% | 2.25M | 2.24M |
| Common Stock Indirect | 3/16/2026 | S · Sale | −1.99K | $101.68 | $202.44K | 0.1% | 2.24M | 2.24M |
| Common Stock Indirect | 3/17/2026 | S · Sale | −2.50K | $102.43 | $256.08K | 0.1% | 2.24M | 2.24M |
| Total | −7.50K | -$762.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned162.95K
Common Stock
IndirectShares owned2.06M
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 162.95K | Indirect |
| Common Stock | 2.06M | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported